中低收入国家成人疫苗可预防疾病现状评估与免疫倡导政策潜力
到2050年,65岁以上成人数量将达5岁以下人口的两倍,且主要集中在低中收入国家。该综述基于肺炎球菌病、流感和带状疱疹的流行病学与经济负担文献及卫生系统障碍,发现成人免疫证据与政策多集中于高收入国家,低中收入国家证据有限,亟需加强证据基础与政治承诺以推动全球成人免疫共识。
要点
- 成人免疫证据与政策集中于高收入国家,低中收入国家数据有限。
- 多数国家儿童免疫规划完善,但成人免疫规划与交付平台严重滞后。
- 需强化证据基础与政治承诺,推动全球成人免疫技术共识。
核心结论
- 全球成人疾病负担与经济成本可观,但低中收入国家证据有限,成人免疫规划与政策远落后于儿童免疫。
- 需要加强证据基础和政治承诺,以推动全面的全球成人免疫技术共识。
研究设计与样本
- 基于对肺炎球菌病、流感和带状疱疹的流行病学与经济负担,以及成人免疫的卫生系统和政策障碍的现有文献综述。
主要发现
- 成人免疫及成人疾病健康经济负担的证据高度集中于高收入国家。
- 少数报告成人免疫政策的国家通常聚焦高危人群。
- 多数国家儿童免疫规划健全,但成人免疫规划与政策严重滞后且缺乏适当交付平台。
- 全球成人疾病负担与经济成本可观,但低中收入国家证据有限。
临床怎么用
- 在低中收入国家推进成人免疫时,应优先弥补肺炎球菌病、流感和带状疱疹的本地流行病学与经济负担证据缺口。
- 倡导将成人免疫纳入健康老龄化策略,并建立适宜的成人免疫交付平台与政策框架。
局限性
- 证据基础主要来自高收入国家,低中收入国家数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
By 2050, the number of adults over 65 years of age will be double the under-5 population, and heavily concentrated in low- and middle-income countries. Population growth and increasing life expectancies call for effective healthy aging strategies inclusive of immunization to reduce the burden of vaccine-preventable diseases, improve quality of life, and mitigate antimicrobial resistance. Based on a review of available literature on the pneumococcal disease, influenza, and herpes zoster epidemiology and economic burden, and the health systems and policy barriers for adult immunization, we identified evidence gaps and considerations for prioritizing adult immunization. The body of evidence for adult immunization and the health and economic burden of adult disease is heavily concentrated in high-income countries. The few countries reporting adult immunization policies generally focus on high-risk groups. Despite robust child immunization programs in most countries, adult immunization programs and policies lag far behind and there is a general lack of appropriate delivery platforms. Global adult disease burden and economic costs are substantial but evidence from low- and middle-income countries is limited. There is a need for a strengthened evidence base and political commitment to drive a comprehensive, global technical consensus on adult immunization.
引用
- Sauer M, Vasudevan P, Meghani A, et al. Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries. Vaccine. 2021. PMID: 33618947. doi:10.1016/j.vaccine.2021.01.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。